Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$49.32
+0.18%
Mkt Cap $3.62B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (19 analysts)
$75.14
Range $65.00 – $82.00
Implied Upside
+52.4%
Consensus $75.14 vs current $49.32
NASDAQ·Healthcare·Biotechnology
$49.32
+0.18%
Mkt Cap $3.62B
Buy
11
Hold
0
Sell
0
Price Target (19 analysts)
$75.14
Range $65.00 – $82.00
+52.4%
Consensus $75.14 vs current $49.32